Announcing new Editor-in-Chief of AAPS Open: Dr. Andrea Allmendinger

AAPS Open is proud to announce new Editor-in-Chief Dr. Andrea Allmendinger. Dr. Allmendinger obtained her PhD in Pharmaceutical Technology from the University of Basel and joined the Pharmaceutical Development department of Roche/Genentech in Basel in 2013, where she is responsible for formulation and process development for clinical Phase I-III projects and commercial transfer activities for both large molecules and for synthetic drugs.

In addition to her responsibilities as a lecturer, Dr. Allmendinger is building a research group at the University of Freiburg in the department of Pharmaceutical Technology and Biopharmacy. She is a regularly invited speaker at international conferences, has a strong publication and reviewer record, and is enthusiastic about driving innovative projects across functional disciplines.

Under her new editorship and vision, AAPS Open welcomes reports from experimental or theoretical studies during the entire course of development of a drug candidate, for both synthetic drugs as well as biopharmaceutical products including vaccines, cell and gene therapeutics, and other new modalities such as nucleotide-based therapeutics. Submit here

Working on a manuscript?

Avoid the most common mistakes and prepare your manuscript for journal editors.

Learn more